how glp 1 medications are changing consumer behavior GLP-1: Transforming weight loss and the food industry Frontiers | Revisiting food addiction

These tests include checking levels of urine albumin (microalbuminuria) and serum creatinine

For Mounjaro (diabetes indication), gastrointestinal effects predominate, including nausea (12-24%), diarrhea (13-22%), decreased appetite (9-11%), vomiting (6-10%), constipation (5-7%), and abdominal pain (5-9%)

It is not intended for self-diagnosis, treat, cure, or prevent any disease

Injectables may be reserved for acute, hospital-based situations or severe oxidative stressbut are not ideal for long-term outpatient management

In conclusion, this review synthesizes molecular insights and clinical evidence to underscore GLP-1RAs potential as multi-targeted disease-modifying agents, urging further research to translate preclinical promise into safe, effective ocular therapies